Samsung, S. Korea Giant, To Invest In Biologics, Device Markets
This article was originally published in PharmAsia News
South Korea's Samsung plans to invest heavily in the health and green energy industries over the next 10 years
You may also be interested in...
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.
The Global Self-Care Federation is looking to consolidate the shift towards self-care seen during the pandemic by promoting trust, innovation and growth in policy. An upcoming webinar hosted by the GSCF will also explore the theme of "Advancing Trust in the Self-Care Industry."